| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |